Clinical trial
Duration of Dual Anti-Platelet Therapy in Acute Coronary Syndrome
NCT03252249 is registered in ClinicalTrials.gov with University of Edinburgh as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Duration of Dual Anti-Platelet Therapy in Acute Coronary Syndrome
- Lead sponsor
- University of Edinburgh
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- December 11, 2018
- Completion date
- February 4, 2023
- Enrollment
- 5,094 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.